An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1 (NCT01494701)
Clinical trial NCT01780246 · COMPLETED
Trial details
- NCT number
- NCT01780246
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-31
- Primary completion
- 2014-02-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.